Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • COVID-19
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • Topics A-Z
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • COVID-19
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • Topics A-Z
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in
  • Log out

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
  • Log out
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

Share

January 01, 1995; 45 (1) Articles

FDG-PET and volumetric MRI in the evaluation of patients with partial epilepsy

W. D. Gaillard, S. Bhatia, S. Y. Bookheimer, S. Fazilat, S. Sato, W. H. Theodore
First published January 1, 1995, DOI: https://doi.org/10.1212/WNL.45.1.123
W. D. Gaillard
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Bhatia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Y. Bookheimer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Fazilat
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Sato
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
W. H. Theodore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
FDG-PET and volumetric MRI in the evaluation of patients with partial epilepsy
W. D. Gaillard, S. Bhatia, S. Y. Bookheimer, S. Fazilat, S. Sato, W. H. Theodore
Neurology Jan 1995, 45 (1) 123-126; DOI: 10.1212/WNL.45.1.123

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
44

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Abstract

Article abstract-We performed interictal FDG-PET- and MRI-based hippocampal volumetric measurements on 18 adult patients with complex partial epilepsy of temporal lobe origin in whom we had identified their ictal focus by video-telemetry EEG. Sixteen patients (89%) had regional hypometabolism, 11 (61%) had focal 1.5-tesla T2-weighted MRI (two structural abnormalities, nine hippocampal formation (HF) increased T2 signal), and nine (50%) had absolute HF atrophy ipsilateral to the temporal ictal focus. Ten (55%) had abnormal L/R HF ratios, nine ipsilateral to the EEG focus. All patients with abnormal MRI volumetric studies had focal PET abnormalities. Only seven had both abnormal HF volume ratios and T2 MRI (all increased HF T2 signal). There was a significant correlation between hippocampal volume and inferior mesial and lateral temporal lobe cerebral metabolic rate of glucose asymmetry index (p < 0.01), suggesting that hypometabolism may reflect hippocampal atrophy. PET is more sensitive than MRI volumetry in identifying the ictal focus but does not provide additional information when HF atrophy is present.

NEUROLOGY 1995;45: 123-126

Positron emission tomography with Fluorine-18-fluorodeoxyglucose (FDG-PET) and MRI are the most useful of the many noninvasive radiologic techniques that identify the epileptogenic zone in patients with complex partial seizures (CPS). FDG-PET identifies a metabolic abnormality ipsilateral to the seizure focus in 60 to 85% of patients with temporal lobe onset [1-6]. Focal abnormalities on T2-weighted MRI are present in a high proportion of subjects with CPS who are candidates for surgery, particularly when mesial temporal sclerosis (MTS) is present and a field strength of 1.5 tesla is used [7-12]. Several studies suggest interictal FDG-PET may be more sensitive in identifying epileptogenic zones than T2 MRI [8,9,13-16]. MRI volumetry, however, may identify hippocampal formation (HF) atrophy associated with MTS with greater sensitivity and specificity than T2 MRI [17-19].

The pathophysiologic basis for hypometabolism in temporal lobe epilepsy is uncertain. Many studies report relatively greater lateral than mesial reduction even though pathologic findings are more prominent mesially [4,5,20]. We compared the utility of volumetric MRI and FDG-PET in seizure focus localization in patients with complex partial epilepsy of temporal lobe origin and examined the relationship between HF volume and temporal lobe metabolism.

Methods. Patients. Eighteen consecutive patients from the NINDS Clinical Epilepsy Section Clinic who had a temporal lobe ictal focus demonstrated by scalp-sphenoidal EEG-telemetry (four patients had subdural EEG monitoring) were enrolled in this study after informed consent was obtained. Eleven patients were male and seven were female (table). The mean age at the time of study was 29 years (range, 15 to 41 years), and mean age at seizure onset was 9 years (1 to 18 years). All patients had CPS, 12 had simple partial seizures, and 16 had secondarily generalized seizures. Eight patients had a right temporal focus and 10 a left temporal focus. Seven patients were treated with a single antiepileptic drug (AED) at the time of PET, 12 were on two or more AEDs, and one was on either felbamate or placebo. All patients had 1.5-T MRI and FDG-PET.

PET. Interictal PET studies were performed on the Scanditronix 2048-15B scanner with a full-width half-maximum axial and in-plane resolution of 5.5 mm, scanning 15 simultaneous slices 6.6 mm apart. Scans were performed following a 4-hour fast in the awake resting state with eyes patched and ears plugged. Heads were immobilized by a thermoplastic mask and scans oriented along the canthomeatal plane. A measured attenuation scan was performed using a Germanium-68/Gallium-68 rotating pin source. Five mCi FDG was injected. Following a 30-minute uptake period, data were acquired over two 15-minute intervals. Continuous EEG was performed and patients observed by an investigator (W.D.G.) to exclude ictal activity. Fifteen patients had arterial sampling and absolute local cerebral metabolic rate of glucose (LCMRGlc; mg glc/min/100 g) measured [21]. Regional values normalized to whole brain counts were used in the three patients who did not have arterial sampling.

PET was analyzed using a standard template of 176 regions, 6-mm square, grouped into 13 paired anatomic areas placed on seven slices. Particular interest was directed to the temporal regions formed of 74 regions of interest arranged into four paired areas. An asymmetry index (AI) was calculated for each paired area: (right - left)/((right + left)/2). Normal volunteer data using this template and scanner demonstrated mean 2 SDs in AI to be 0.128; hence, an asymmetry greater than 12.8% was considered significant and indicating regional hypometabolism [22].

MRI. MRI was performed on the General Electric Medical Systems (Milwaukee, WI) Signa 1.5-T scanner in contiguous 2-mm-thick coronal slices with the following acquisition parameters: TR, 24 msec; TE, 5 msec; flip angle, 45 degrees; field of view, 24 x 24 cm; and matrix, 256 x 256. The voxel size was 0.9375 x 0.9375 x 2 cubic mm. Scans were obtained perpendicular to the orbitomeatal plane. The HF was outlined on each coronal image from the pes hippocampi anteriorly to the fasciolar gyrus at the level of the pulvinar. Voxels from each region were summed from each successive picture to calculate hippocampal volume as described previously [23].

HF volume data were compared to previously established normative data based on 29 normal volunteers [23]. HF atrophy was considered present if absolute HF volume was beyond 2 SDs for normal subjects and deemed strongly suggestive of relative atrophy if the HF ratio, L/R, was beyond 2 SDs [24].

Results. Nine patients had absolute HF atrophy, all ipsilateral to the ictal focus Table 1. Eight of these had abnormal HF ratios. Two other patients had abnormal ratios, one of which was falsely lateralizing compared with the ictal EEG. Both of these patients had properly lateralizing FDG-PET.

View this table:
  • View inline
  • View popup
  • Download powerpoint

Table 1. Patient characteristics, ictal EEG, PET, MRI, and pathology results

PET demonstrated focal temporal hypometabolism in 16 of 18 patients (89%), all ipsilateral to the ictal EEG focus. Most subjects had regional hypometabolism in the inferior lateral (11 patients) and mesial (nine patients) structures (table). Five subjects had regional hypometabolism extending beyond the temporal regions to adjacent frontal (four patients) or occipital (one patient) cortical areas. In our previous studies, using an older scanner and template, 2 SDs for normative AI was 0.150 [4,5]. All patients in this study with focal PET had at least one temporal region with an AI greater than 0.150. Using an AI of 0.128 indicated more extensive temporal hypometabolism in two patients and showed adjacent frontal hypometabolism in one other patient.

All patients with absolute HF atrophy had ipsilateral temporal hypometabolism. However, six patients with focal PET had normal HF volumes, two of whom had structural lesions (one a region of temporal encephalomalacia, the other a temporal tip vascular malformation). Eleven had abnormalities seen on T2 MRI (in nine there was increased T2 signal in HF and in two the structural abnormalities described above), which in two cases were not seen on either volumetry or PET. Four patients had abnormal volumetry (one falsely lateralizing) but normal T2 MRI.

Nine patients had temporal lobectomy; eight are seizure free (mean follow-up, 28 months; range, 11 to 38 months). Pathology of resected tissue in these eight patients showed varying degrees of gliosis, neuron loss, and rare subcortical neurons; a pathologic diagnosis could not be made in two subjects. Pathologic studies were limited, since only portions of resected brain were available for review and the HFs were not removed en bloc for microscopic study. One patient (subject 8) has persistent seizures, although moderately decreased in frequency: he had left hemispheric onset on invasive monitoring thought to arise from the temporal region, left superior temporal and frontal hypometabolism, and an abnormal HF ratio suggesting relative contralateral atrophy. However, both hippocampi were more than 2 SDs larger than normal control values, and pathologic study of resected temporal tissue was normal. Either the temporal focus was not completely resected or the residual focus is frontal.

There were statistically significant correlations between HF volume ratio and AI for CMRGlc in the inferior lateral and inferior mesial temporal areas (r = 0.67, p < 0.01; r = 0.72, p < 0.01, excluding subject 8) Figure 1 and Figure 2. Also, there were significant correlations between absolute HF volume and regional CMRGlc in inferior lateral and inferior mesial, but not middle and superior, temporal areas (r = 0.412, p < 0.034; r = 0.539, p < 0.006; r = 0.308, p < 0.10; r = 0.119, p < 0.33).

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 1. Relationship between hippocampal formation volume ratio (L/R) and inferior lateral temporal (ILT) cortex CMRGlc percent asymmetry ((AI) x 100)

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 2. Relationship between hippocampal formation volume ratio (L/R) and inferior mesial temporal (IMT) cortex CMRGlc percent asymmetry ((AI) x 100)

Discussion. We found that PET is superior to either HF volume measurements or T2-weighted MRI in temporal lobe CPS focus localization. MRI volumetry and T2 MRI were of equivalent use in detecting focal abnormalities. PET provided additional information to MRI in 22% of patients. Although PET proved more sensitive than volumetric MRI, when atrophy was present, PET did not provide additional information. Although PET hypometabolism and hippocampal atrophy predict successful temporal lobectomy, discordant studies or large hippocampal volumes may suggest higher risk for a poor surgical outcome and merit greater caution in surgical evaluation [5,17]. Regional temporal hypometabolism, in part, appears to reflect HF atrophy.

We used an AI, rather than absolute measures, to determine PET regional hypometabolism. Due to interindividual variability, absolute values may be a less reliable measure of relative hypometabolism. In addition, the effect of AEDs, which reduce global CMRGlc but not the degree of asymmetry, can be ignored [22,25-28]. Even when bilateral temporal hypometabolism was present in nine patients, significant asymmetry could be demonstrated in every subject; these nine patients also had global reductions in CMRGlc. Moreover, FDG AI predicts outcome after temporal lobectomy [5,29]. Both absolute HF volume measurements and L/R HF volume ratios can identify epileptic foci [17-19,24,30]. MRI volume measurements are probably not affected by AEDs.

The majority of patients who undergo temporal lobectomy have varying degrees of gliosis and neuronal loss [14,31-37]. HF atrophy may be proportional to gliosis and cell loss [18,19]. Although previous FDG-PET studies have not noted any correlation between extent or degree of metabolic abnormality and degree of pathologically identified gliosis, [14,38] our results suggest an association between temporal cortical metabolism and HF volume. In some patients the more prominent hypometabolism in lateral than mesial cortex may reflect decreased function in projection fields of gliotic hippocampus or technical factors such as partial volume averaging [4,5,20,39]. There may be other causes for temporal lobe hypometabolism, as when a structural lesion, such as a vascular malformation or tumor, or a neocortical focus is present. In these latter circumstances, normal HF volumes are found.

Six of the eight subjects whose LCMRGlc and hippocampal volumes both fell below 2 SDs had a history of febrile seizures. Several previous authors have found an association between prolonged febrile seizures and hippocampal atrophy [31,40,41]. A significant early insult may lead to sclerosis, atrophy, and an increased risk for seizures. Early recurrent seizures may also cause progressive neuronal loss [37,42]. Comparison of PET and MRI results may be facilitated by registration using digital image processing. Although this approach may improve analysis of the relationship between volume and metabolism analysis, partial volume effects will still occur in small structures such as the hippocampus.

Both FDG-PET and MRI are valuable tools for the identification of the epileptogenic zones in patients with CPS of temporal lobe origin. We suggest that MRI volumetry and T2 MRI be performed first. MRI is more readily available than PET and, when abnormal, may demonstrate a cause for the seizures as well as assist in planning surgical resection. If these studies are not revealing, then FDG-PET should be performed. To reduce the cost as well as the morbidity associated with epilepsy surgery evaluation, it is important to use both techniques selectively and to avoid redundant studies.

Acknowledgments

We thank Drs. D. Katz, O. Devinsky, and E. Bromfield for providing pathology results.

  • Copyright 1995 by Modern Medicine Publications, Inc., a subsidiary of Edgell Communications, Inc.

REFERENCES

  1. 1.↵
    Engel J Jr, Kuhl DE, Phelps ME, Crandal P. Comparative localization of epileptic foci in partial epilepsy by PCT and EEG. Ann Neurol 1982;12:529-537.
    OpenUrl
  2. 2.
    Engel J Jr, Henry TR, Risinger MW, et al. Presurgical evaluation for partial epilepsy: relative contributions of chronic depth-electrode recordings versus FDG-PET and scalp-sphenoidal ictal EEG. Neurology 1990;40:1670-1677.
    OpenUrlAbstract/FREE Full Text
  3. 3.
    Theodore WH, Newmark ME, Sato S, et al. 18-F-Fluorodeoxyglucose positron emission tomography in refractory partial seizures. Ann Neurol 1983;14:429-437.
    OpenUrl
  4. 4.↵
    Theodore WH, Fishbein D, Dubinsky R. Patterns of cerebral glucose metabolism in patients with partial seizures. Neurology 1988;38:1201-1206.
    OpenUrlPubMed
  5. 5.↵
    Theodore WH, Sato S, Kufta C, et al. Temporal lobectomy for uncontrolled seizures: the role of positron emission tomography. Ann Neurol 1992;32:789-794.
    OpenUrl
  6. 6.
    Abou-Khalil BW, Siegel GJ, Sackellares JC, et al. Positron emission tomography studies of cerebral glucose metabolism in chronic partial epilepsy. Ann Neurol 1987;22:480-486.
    OpenUrlCrossRefPubMed
  7. 7.↵
    Lesser RP, Modic MT, Weinstein MA, et al. Magnetic resonance imaging (1.5 tesla) in patients with intractable focal seizures. Arch Neurol 1986;43:367-371.
    OpenUrl
  8. 8.↵
    Sperling MR, Wilson G, Engel J Jr, et al. Magnetic resonance imaging in intractable partial epilepsy: correlative studies. Ann Neurol 1986;20:57-62.
    OpenUrl
  9. 9.
    Theodore WH, Dorwart R, Holmes M, Porter RJ, DiChiro G. Neuroimaging in refractory partial seizures: comparison of PET, CT, and MRI. Neurology 1986;36:750-759.
    OpenUrlAbstract/FREE Full Text
  10. 10.
    Kuzniecky R, de la Sayette V, Ethier R, et al. Magnetic resonance imaging on temporal lobe epilepsy: pathological correlations. Ann Neurol 1987;22:341-347.
    OpenUrl
  11. 11.
    Jackson GD, Berkovic SF, Tress BM, Kalnins RM, Fabinyi GCA, Bladin PF. Hippocampal sclerosis can be reliably detected by magnetic resonance imaging. Neurology 1990;40:1869-1875.
    OpenUrlAbstract/FREE Full Text
  12. 12.
    Berkovic SF, Andermann F, Olivier A, et al. Hippocampal sclerosis in temporal lobe epilepsy demonstrated by magnetic resonance imaging. Ann Neurol 1991;29:175-182.
    OpenUrlPubMed
  13. 13.
    Sperling MR. Neuroimaging in epilepsy: contribution of MRI, PET and SPECT. Semin Neurol 1990;10:349-356.
    OpenUrl
  14. 14.↵
    Theodore WH, Katz D, Kufta C, et al. Pathology of temporal lobe foci: correlation with CT, MRI, and PET. Neurology 1990;40:797-803.
    OpenUrlPubMed
  15. 15.
    Stefan H, Pawlik G, Bocher-Schwarz HG, et al. Functional and morphological abnormalities in temporal lobe epilepsy: a comparison of interictal and ictal EEG, CT, MRI, and PET. J Neurol 1987;234:377-384.
    OpenUrl
  16. 16.
    Ryvlin P, Philippon B, Cinotti L, et al. Functional neuroimaging strategy in temporal lobe epilepsy: a comparative study of 18-FDG-PET and 99mTc-HMPAO-SPECT. Ann Neurol 1992;31:650-656.
    OpenUrl
  17. 17.↵
    Jack CR, Sharbrough FW, Cascino GD, et al. Magnetic resonance image-based hippocampal volumetry: correlation with outcome after temporal lobectomy. Ann Neurol 1992;31:138-146.
    OpenUrl
  18. 18.↵
    Cascino GD, Jack CR, Parisi JE, et al. Magnetic resonance imaging-based volume studies in temporal lobe epilepsy: pathological correlations. Ann Neurol 1991;30:31-36.
    OpenUrlCrossRefPubMed
  19. 19.
    Lencz T, McCarthy G, Bronen RA, et al. Quantitative magnetic resonance imaging in temporal lobe epilepsy: relationship to neuropathology and neuropsychological function. Ann Neurol 1992;31:629-637.
    OpenUrl
  20. 20.
    Sackellares JC, Siegel GJ, Abou-Khalil BW, et al. Differences between lateral and mesial temporal metabolism interictally in epilepsy of mesial temporal origin. Neurology 1990;40:1420-1426.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    Brooks RA. Alternate formula for glucose utilization using labelled deoxyglucose. J Nucl Med 1982;23:538-539.
    OpenUrl
  22. 22.↵
    Gaillard WD, White S, Fazilat S, et al. Effect of valproate on cerebral glucose metabolism and cerebral blood flow as determined by 18-FDG-PET and O-15 water PET (abstract). Epilepsia 1992;33(suppl 3):54.
  23. 23.↵
    Bhatia S, Bookheimer SY, Gaillard WD, Theodore WH. Measurement of whole temporal lobe and hippocampus for MR volumetry: normative data. Neurology 1993;43:2006-2010.
    OpenUrl
  24. 24.↵
    Bhatia S, Gaillard WD, Bookheimer SY, et al. Magnetic resonance volumetry in patients with complex partial seizures (abstract). Epilepsia 1992;33(suppl 3):49.
  25. 25.
    Theodore WH, DiChiro G, Margolin R, Fishbein D, Porter RJ, Brooks RA. Barbiturates reduce human cerebral glucose metabolism. Neurology 1986;36:60-64.
    OpenUrl
  26. 26.
    Theodore WH, Bairamian D, Newmark ME, et al. Effect of phenytoin on human cerebral glucose metabolism. J Cereb Blood Flow Metab 1986;6:315-320.
    OpenUrlPubMed
  27. 27.
    Theodore WH, Bromfield E, Onorati L. The effect of carbamazepine on cerebral glucose metabolism. Ann Neurol 1989;25:516-520.
    OpenUrl
  28. 28.
    Leiderman DB, Balish M, Bromfield E, Theodore WH. Effect of valproate on human cerebral glucose metabolism. Epilepsia 1991;32:417-422.
    OpenUrlPubMed
  29. 29.
    Radtke RA, Hanson MW, Hoffman JM, et al. Temporal lobe hypometabolism on PET: predictor of seizure control after temporal lobectomy. Neurology 1993;43:1088-1092.
    OpenUrlAbstract/FREE Full Text
  30. 30.
    Jack CR, Sharbrough FW, Twomey CK, et al. Temporal lobe seizures: lateralization with MR volume measurements of the hippocampal formation. Radiology 1990;175:423-429.
    OpenUrl
  31. 31.↵
    Cendes F, Andermann F, Gloor P, et al. MRI volumetric measurement of amygdala and hippocampus in temporal lobe epilepsy. Neurology 1993;43:719-725.
    OpenUrl
  32. 32.
    Falconer MA, Serafetinides EA, Corsellis JAN. Etiology and pathogenesis of temporal lobe epilepsy. Arch Neurol 1964;10:233-248.
    OpenUrl
  33. 33.
    Margerison JH, Corsellis JAN. Epilepsy and the temporal lobes. Brain 1966;89:499-530.
    OpenUrl
  34. 34.
    Engel J Jr, Brown WJ, Kuhl DE, et al. Pathological findings underlying focal temporal lobe hypometabolism in partial epilepsy. Ann Neurol 1982;12:518-528.
    OpenUrl
  35. 35.
    Babb TL, Brown WJ, Pretorius J, et al. Temporal lobe volumetric cell densities in temporal lobe epilepsy. Epilepsia 1984;25:729-740.
    OpenUrl
  36. 36.
    Bruton CJ. The neuropathology of temporal lobe epilepsy. Oxford, UK: Oxford University Press, 1988.
  37. 37.↵
    Hudson LP, Munoz DG, Miller L, et al. Amygdaloid sclerosis in temporal lobe epilepsy. Ann Neurol 1993;33:622-631.
    OpenUrl
  38. 38.
    Henry TR, Engel J Jr, Babb TL, Phelps ME. Correlation of neuronal cell loss with degree of interictal focal temporal hypometabolism in complex partial epilepsy (abstract). Neurology 1988;38(suppl 1):156.
  39. 39.
    Hajek M, Antonini A, Leenders KL, Wieser HG. Mesiobasal versus lateral temporal lobe epilepsy: metabolic differences in the temporal lobe shown by interictal Fluorine-18-FDG positron emission tomography. Neurology 1993;43:79-86.
    OpenUrl
  40. 40.
    Falconer MA. Mesial temporal (Ammon's horn) sclerosis as a cause of epilepsy: etiology, treatment, and prevention. Lancet 1974;2:767-770.
    OpenUrlPubMed
  41. 41.
    Barr WB, Manzar A, Schaul N. Hippocampal volume reductions in adults with a history of febrile seizures (abstract). Epilepsia 1992;33(suppl 3):71.
  42. 42.
    Mouritzen-Dam A. Epilepsy and neuron loss in the hippocampus. Epilepsia 1980;21:617-629.
    OpenUrlPubMed

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • Acknowledgments
    • REFERENCES
  • Figures & Data
  • Info & Disclosures
Advertisement

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • Neurology: Education
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2022 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise